Piribedil (trade name: CLARIUM)
Showing 1 - 25 of 922
Real-World Evidence on Cardiovascular Safety of CONTRAVE® in
Completed
- Obesity
-
Brentwood, TennesseeCurrax Pharmaceuticals
Oct 17, 2023
Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin
Not yet recruiting
- Pain
- Insomnia
- Compound ibuprofen polyrelease tablets
- reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Feb 6, 2023
Overactive Bladder, Urinary Incontinence in Old Age, Urgency Urinary Incontinence Trial (Botox 50 Unit Injection, Botox 100 Unit
Not yet recruiting
- Overactive Bladder
- +2 more
- Botox 50 Unit Injection
- Botox 100 Unit Injection
- (no location specified)
Aug 19, 2022
Recurrent Head Neck Cancer, Carcinoma, Squamous Cell of Head and Neck Trial in Baltimore, Philadelphia, Pittsburgh
Recruiting
- Recurrent Head and Neck Cancer
- Carcinoma, Squamous Cell of Head and Neck
- Reirradiation
- MK-3475
-
Baltimore, Maryland
- +3 more
Mar 25, 2022
Mycoplasma Genitalium Infection Trial in Seattle (Lefamulin, Doxycycline)
Recruiting
- Mycoplasma Genitalium Infection
-
Seattle, WashingtonUniversity of Washington
Apr 25, 2022
Sites to Test Whether SAMANTA Questionnaire That is Used to
Completed
- Menorrhagia
- Chronic hormonal treatment
-
Multiple Locations, SpainMany locations
Mar 29, 2022
Bariatric Surgery Candidate, Post-operative Pain Trial in Richmond (Treatment with liposomal bupivacaine, Treatment with
Recruiting
- Bariatric Surgery Candidate
- Post-operative Pain
- Treatment with liposomal bupivacaine
- Treatment with standard bupivacaine
-
Richmond, VirginiaVirginia Commonwealth University
Oct 12, 2023
Hypertension Trial in Dongguan (Felodipine sustained release tablets (trade name: plendil®), Felodipine Controlled Release
Active, not recruiting
- Hypertension
- Felodipine sustained release tablets (trade name: plendil®)
- Felodipine Controlled Release Tablets
-
Dongguan, Guangdong, ChinaClinical Trial Centre of Dongguan Kanghua Hospital
Jan 31, 2023
Biochemical Recurrence of Malignant Tumor of Prostate, Prostate Cancer, BCR Prostate Carcinoma Trial in China (68Ga-PSMA-11,
Not yet recruiting
- Biochemical Recurrence of Malignant Neoplasm of Prostate
- +2 more
- 68Ga-PSMA-11
- PET/CT or PET/MRI
-
Changsha, China
- +5 more
Apr 26, 2023
Lymphedema of Upper Arm, Breast Cancer Trial in Durham (Constructive Shearwave Interference (CSI))
Recruiting
- Lymphedema of Upper Arm
- Breast Cancer
- Constructive Shearwave Interference (CSI)
-
Durham, North Carolina
- +1 more
May 31, 2022
Erythema Multiforme Trial in Philadelphia (Apremilast)
Recruiting
- Erythema Multiforme
-
Philadelphia, PennsylvaniaPerelman Center For Advanced Medicine
May 16, 2023
Epilepsy Trial in Wuhan (Lacosamide Tablets, Lacosamide extended release tablets)
Not yet recruiting
- Epilepsy
- Lacosamide Tablets
- Lacosamide extended release tablets
-
Wuhan, Hubei, ChinaUnion Hospital of Tongji Medical College of Huazhong University
Mar 15, 2023
Hypertension Trial in Guangdong (Amlodipine besylate tablets (trade name: Norfloxacin ®), Amlodipine besylate controlled-release
Not yet recruiting
- Hypertension
- Amlodipine besylate tablets (trade name: Norfloxacin ®)
- Amlodipine besylate controlled-release tablets
-
Guangdong, Guangzhou, ChinaZhujiang Hospital of Southern Medical University
Jan 3, 2023
Multiple Sclerosis Trial in Edmonton, London, Toronto (Adderall XR)
Recruiting
- Multiple Sclerosis
- Adderall XR
-
Edmonton, Alberta, Canada
- +2 more
Apr 4, 2022
Arthritis, Psoriatic Trial in Beijing (99Tc methylene diphosphonate)
Completed
- Arthritis, Psoriatic
- 99Tc methylene diphosphonate
-
Beijing, Dongcheng, ChinaPeking Union Medical College hospital
Aug 3, 2021
Iron Deficiency, Anaemia Trial in China (Ferric Carboxymaltose Injection, Ferric Carboxymaltose Injection [Ferinject])
Not yet recruiting
- Iron Deficiency
- Anaemia
- Ferric Carboxymaltose Injection
- Ferric Carboxymaltose Injection [Ferinject]
-
Beijing, Beijing, China
- +3 more
Oct 12, 2023
Malaria Trial in Lambaréné (Vaccine AnAPN1)
Not yet recruiting
- Malaria
- Vaccine AnAPN1
-
Lambaréné, Moyen- Ogooué, GabonCentre de Recherches Médicales de Lammbaréné
Jun 21, 2023
A Study on the Safety of Hakim Programmable Shunt System
Completed
- Hydrocephalus
- Hakim Shunt Programmable System
-
Beijing, Beijing, China
- +4 more
Nov 3, 2021
Tourette Disorder, Tourette Syndrome Trial in New Haven, Tampa, New York (, extended-release guanfacine (Intuniv))
Completed
- Tourette Disorder
- Tourette Syndrome
- placebo
- extended-release guanfacine (Intuniv)
-
New Haven, Connecticut
- +2 more
Aug 11, 2021
Corneal Nerves After Treatment With Cenegermin
Recruiting
- Neurotrophic Keratitis
- Cenegermin Ophthalmic Solution [Oxervate]
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Oct 14, 2022
NSCLC Stage III, EGFR Positive NSCLC, Non-squamous Non-small-cell Lung Cancer Trial in Korea, Republic of (Lazertinib)
Recruiting
- Non-small Cell Lung Cancer Stage III
- +2 more
-
Busan, Korea, Republic of
- +12 more
Jan 17, 2023